A detailed history of Howland Capital Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Howland Capital Management LLC holds 29,454 shares of NEO stock, worth $442,988. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,454
Previous 29,454 -0.0%
Holding current value
$442,988
Previous $408,000 6.37%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$14.06 - $16.79 $181,880 - $217,195
-12,936 Reduced 30.52%
29,454 $463,000
Q3 2023

Oct 17, 2023

BUY
$12.15 - $17.85 $58,806 - $86,394
4,840 Added 12.89%
42,390 $521,000
Q2 2023

Jul 28, 2023

SELL
$14.1 - $19.83 $15,030 - $21,138
-1,066 Reduced 2.76%
37,550 $603,000
Q2 2022

Jul 22, 2022

BUY
$7.06 - $13.97 $23,538 - $46,575
3,334 Added 9.45%
38,616 $315,000
Q4 2021

Jan 26, 2022

SELL
$30.49 - $48.49 $30,490 - $48,490
-1,000 Reduced 2.76%
35,282 $1.2 Million
Q3 2021

Oct 25, 2021

SELL
$41.66 - $52.52 $137,936 - $173,893
-3,311 Reduced 8.36%
36,282 $1.75 Million
Q2 2021

Jul 28, 2021

BUY
$36.62 - $51.69 $50,865 - $71,797
1,389 Added 3.64%
39,593 $1.79 Million
Q1 2021

Apr 28, 2021

BUY
$41.56 - $59.88 $433,595 - $624,728
10,433 Added 37.57%
38,204 $1.84 Million
Q4 2020

Jan 26, 2021

SELL
$36.08 - $56.47 $500,862 - $783,916
-13,882 Reduced 33.33%
27,771 $1.5 Million
Q3 2020

Oct 26, 2020

BUY
$33.26 - $40.48 $343,110 - $417,591
10,316 Added 32.92%
41,653 $1.54 Million
Q4 2018

Jan 23, 2019

BUY
$11.24 - $18.5 $9,981 - $16,428
888 Added 2.92%
31,337 $395,000
Q3 2018

Oct 25, 2018

BUY
$12.5 - $15.38 $108,337 - $133,298
8,667 Added 39.79%
30,449 $467,000
Q4 2017

Feb 01, 2018

BUY
$8.02 - $11.18 $70,431 - $98,182
8,782 Added 67.55%
21,782 $193,000
Q3 2017

Oct 30, 2017

BUY
$9.11 - $11.26 $118,429 - $146,380
13,000
13,000 $145,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.89B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Howland Capital Management LLC Portfolio

Follow Howland Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.